Sujan Piya

6PUBLICATIONS
51CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 26, 2026
Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer.

|Mar 23, 2026
Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer.

André Forjaz, Hengameh Mojdeganlou, Alens Valentin

|Feb 14, 2023
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia.

Seemana Bhattacharya, Sujan Piya, Huaxian Ma

|May 19, 2022
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.

Natalia Baran, Alessia Lodi, Yogesh Dhungana

|Feb 17, 2022
Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL.

Sujan Piya, Yaling Yang, Seemana Bhattacharya

|Jun 09, 2016
Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia.

Sujan Piya, Steven M Kornblau, Vivian R Ruvolo

Pageof 1

Frequent Collaborators

4 joint publications

R Eric Davis

3 joint publications

Gautam Borthakur

3 joint publications

Natalia Baran

3 joint publications

Marina Konopleva